Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AACR In Brief

This article was originally published in The Tan Sheet

Executive Summary

Vitamin E: Dietary and total intake of vitamin E "may have a potential role in reducing [bladder cancer] risk, whereas gamma-tocopherol has no effect," Ladia Hernandez, et al., University of Texas and Texas Women's University, Houston, conclude. Investigators looked at vitamin E intake from dietary sources, diet and supplements, and dietary gamma-tocopherol and "found an inverse relationship between vitamin E intake from dietary sources only and bladder cancer risk [and] a similar inverse relationship was also found for total intake" of vitamin E. Analysis included 468 patients with bladder cancer and 534 control participants who were "frequency-matched on age, gender and ethnicity"...

You may also be interested in...



NCCAM PC-SPES Studies In Limbo After BotanicLab Closes Doors

The National Center for Complementary & Alternative Medicine is evaluating the future of multiple PC-SPES studies it is funding following Brea, Calif.-based BotanicLab's recent announcement it is going out of business

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel